It is a trading private limited company based in Lucknow, Uttar Pradesh, India, established in 2022.
2022 | Lucknow, Uttar Pradesh, India | ActiveGlalet Pharmaceuticals Private Limited, a active private limited company, was established on 24 June 2022 in Lucknow, Uttar Pradesh, India. Engaging in specialty within the trading sector, it holds CIN: U51909UP2022PTC166358. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Formerly known as Glatt Pharmaceuticals Private Limited. Its leadership includes Anchal Srivastava (Whole-Time Director), Prashant Sen Srivastava (Whole-Time Director). It holds ₹8.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 304, 3Rd Floor, Rohit Tower, Haniman Chauraha, Cp-1, Viraj Khand, Gomti Nagar, Lucknow, Uttar Pradesh, 226010.
U51909UP2022PTC166358
166358
24 June 2022
₹0.10 M
₹0.10 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Glalet Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anchal Srivastava | Whole-Time Director | 24 Jun 2022 | Current |
| Prashant Sen Srivastava | Whole-Time Director | 24 Jun 2022 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Glalet Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Glalet Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹8,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Nov 2023 | Others | ₹7.00 M | Open |
| 19 Jul 2023 | Others | ₹1.00 M | Open |
Explore comprehensive loan charge details -
Glalet Pharmaceuticals has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Glalet Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glalet Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Glalet Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Glalet Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was completed.
Progress on A charge with Others amounted to Rs. 7.00 M with Charge ID 100818549 was registered on 01 Nov 2023. was documented.
The activity A charge with Others amounted to Rs. 1.00 M with Charge ID 100762172 was registered on 19 Jul 2023. was completed.
Progress on Anchal Srivastava was appointed as a Whole-time director was appointed as a Whole-time director on 24 Jun 2022 & has been associated with this company since 3 years 5 months . was documented.
Prashant Sen Srivastava was appointed as a Whole-time director was appointed as a Whole-time director on 24 Jun 2022 & has been associated with this company since 3 years 5 months . was recorded as a recent event.
The CIN of Glalet Pharmaceuticals Private Limited is U51909UP2022PTC166358.
Glalet Pharmaceuticals Private Limited is headquartered at 304, 3Rd Floor, Rohit Tower, Haniman Chauraha, Cp-1, Viraj Khand, Gomti Nagar, Lucknow, Uttar Pradesh, 226010.
Glalet Pharmaceuticals Private Limited was incorporated on 24 June 2022.
The current directors of Glalet Pharmaceuticals Private Limited are
The primary industry of Glalet Pharmaceuticals Private Limited is Trading.
Glalet Pharmaceuticals Private Limited is unlisted.
The authorized capital of Glalet Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX